CA-ALKIRA/CHECK-POINT
29.9.2021 16:12:04 CEST | Business Wire | Press release
Cloud networking pioneer Alkira® and Check Point Software Technologies (NASDAQ: CHKP), a leading provider of cyber security solutions globally, today announced a technology alliance to provide Check Point Software’s CloudGuard firewalls in Alkira’s Cloud Network infrastructure as-a-Service (CNaaS). This comes as organizations deploying application workloads to the cloud are struggling with the complexity of implementing consistent enterprise-wide security controls spanning cloud, multi-cloud and on-premises environments.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210929005357/en/
The Check Point CloudGuard platform provides cloud native security with advanced threat prevention for all assets and workloads enabling customers to deploy the same robust security in the cloud that they are used to with on-premises systems. Alkira brings a high-performance cloud network-as-a-service with global virtual infrastructure, advanced routing, intelligent service insertion and dynamic auto-scale, simplifying set-up and day 2 operations for enterprise cloud networking and security deployments.
Atif Khan, CTO and Founder of Alkira, said:
“Alkira and Check Point simplify security deployments and make it easier for enterprise customers to apply a single security posture across the entire enterprise network spanning cloud, multi-cloud and existing data center or colocation facilities. Delivering the Alkira virtual network infrastructure and Check Point security management tools as a service allows enterprises to avoid the costs and complexity of DIY solutions, and provides guaranteed performance and scalability.”
TJ Gonen, Head of Cloud Security at Check Point added
:
“The combination of Check Point CloudGuard and Alkira simplifies the process of provisioning and ongoing management in the cloud networking environment which is a big win for enterprise customers. The Check Point CloudGuard platform provides cloud native security with advanced threat prevention for all assets and workloads, across public, hybrid and multi-cloud environments, enabling customers to benefit from a single unified security platform.”
Alkira Cloud Services Exchange® (CSX) fully automates the provisioning, licensing, service insertion, scaling and health monitoring of CloudGuard network security gateways. Alkira seamlessly inserts the CloudGuard gateways at any point in the Alkira global cloud backbone, providing stateful security controls for any on-premises, cloud, and Internet application traffic. Alkira allows customers to decouple CloudGuard from the specific cloud providers, thus providing a more efficient multi-cloud security architecture.
Cloud environments offer global presence and vast compute resources but lack the necessary routing, policy and operational controls enterprises require for a streamlined cloud firewall deployment. Even in a single cloud environment, do-it-yourself solutions result in a complex sprawl of virtual machine instances and traffic management scenarios. They also tend to make inefficient use of resources. All these problems are made worse in multi-cloud environments.
Check Point CloudGuard can be rapidly provisioned into one or multiple globally distributed Alkira Cloud Exchange Points (CXP) to provide security policy enforcement for application traffic between any set of endpoints connected to the Alkira global cloud backbone. Once CloudGuard has been provisioned within an Alkira CXP it can provide:
- Security policy to and between public clouds
- Cloud hosted, stateful firewall services for branches and data centers
- Regionalized Internet breakouts for secure SaaS application access
- Cloud DMZ environment for Internet facing applications
- Shared cloud application services for partners and M&As
Alkira’s visual policy manager simplifies policy configuration, scoping and inspection, and streamlines auditing for assurance and compliance purposes. Alkira’s intent-based approach selectively routes traffic to firewalls according to need, improving efficiency of firewall utilization and optimizing network performance. Customers have a choice of bring-your-own license (BYOL) or pay-as-you-go (PAYG) licensing models.
Check Point offers a multilevel security architecture that defends enterprises’ cloud, network and mobile device-held information, and a comprehensive and intuitive one-point-of-control security management system.
CloudGuard is available in the Alkira network services marketplace.
For more information:
- Download the Alkira and Check Point solution brief .
- Join the Alkira and Checkpoint webinar October 13
About Alkira
Alkira® delivers Cloud Networking as-a-Service (CNaaS) and developed the first Network Cloud which enables enterprises to build and deploy a secure global unified multi-cloud network infrastructure as-a-service that delivers network connectivity, advanced network and security services, and end-to-end visibility and governance. Alkira Cloud Services Exchange® (CSX) seamlessly and securely connects branches, data centers, remote users and clouds. Alkira CSX is available on the AWS and Azure Marketplaces. Alkira was founded by CEO Amir Khan, founder and former CEO of Viptela, and Atif Khan, CTO, former VP and founding team member at Viptela. Alkira has raised $76M from Sequoia Capital, Kleiner Perkins, Koch Disruptive Technologies, LLC, and GV Capital (formerly Google Ventures). Learn more at www.Alkira.com or follow us @AlkiraNet
Alkira® , Alkira Cloud Services Exchange® and Alkira Cloud Exchange Point® are registered trademarks of Alkira, Inc. All other marks are the property of their respective owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210929005357/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
AI Meets Traditional Culture: Huangshan Captures Widespread Attention at ITB Berlin7.3.2026 10:22:00 CET | Press release
Huangshan, one of China’s most iconic scenic destinations, drew significant attention at this year’s ITB by presenting a compelling fusion of traditional Chinese culture and cutting-edge artificial intelligence under the slogan “The world of Huangshan is for the world.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260307909978/en/ International visitor admires Huangshan cultural and creative exhibits at the Huangshan stand during ITB Berlin. Located in eastern China’s Anhui Province, Huangshan is famed for its “Five Natural Wonders” — fantastic pines, grotesque rocks, sea of clouds, hot spring and winter snow. The mountain is widely regarded as one of China’s greatest mountain landscapes. It is also a rare natural heritage site that simultaneously holds multiple international designations, including UNESCO World Cultural and Natural Heritage status, a UNESCO Global Geopark and a World Biosphere Reserve. At ITB, the Huangsh
Incyte Announces the European Commission Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)6.3.2026 22:42:00 CET | Press release
- Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) is the first systemic treatment for adult patients with advanced SCAC in Europe- The EC approval is based on results of the POD1UM-303 study which showed that adult patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment compared to chemotherapy alone.1 Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “The EC approval of Zynyz marks an important step forward for patients with advanced SCAC, a rare cancer for which meaningful treatment advances have not occurred in several decades,” said Bill Meur
Dfns Launches Payouts6.3.2026 21:27:00 CET | Press release
Dfns today announced the launch of Payouts, a new API enabling institutions to convert stablecoins to fiat and route payouts across multiple bank accounts while keeping wallet-level governance and controls in place. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305327930/en/ Convert stablecoins to fiat and settle payouts to bank accounts in 94 countries, today. Solving the problem of single-rail off-ramps Today, most fintechs and institutions still hard-wire a single payout provider into their stack, or rely on vertically integrated models that bundle routing, pricing, custody, and settlement together. That approach may be convenient early on, but it creates structural problems at scale: weak price discovery because there is no competitive pressure on margins, limited auditability because routing decisions are opaque, and operational fragility because a single provider degradation in any corridor requires architectural i
Klarna Group Plc Clarifies Mechanics of March 9 Lock-Up Expiration6.3.2026 20:23:00 CET | Press release
Klarna Group plc (NYSE: KLAR) today issues the following clarification to ensure investors and market participants have accurate information regarding the mechanics of its lock-up expiration on March 9, 2026, the processes required before pre-IPO shares can be traded on the NYSE, and the prior liquidity opportunities already available to shareholders. This release contains only factual descriptions of the Company's share structure and applicable processes. It does not constitute guidance or a projection of any kind regarding future trading volumes, share price, or the intentions of any shareholder and speaks only as of the date of this press release. 1. 335 million locked-up shares — but two different categories Of the 378 million total ordinary shares outstanding, approximately 335 million are subject to lock-up restrictions expiring March 9, 2026. However, these shares fall into two distinct categories governed by separate sets of regulations. A. 159 million shares (48% of locked-up
Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG6.3.2026 18:30:00 CET | Press release
Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position in the business. Headquartered in Basel, Switzerland, CHI operates globally across the Americas, Europe and Asia Pacific. The business comprises three segments: Hard Empty Capsules: leading global manufacturer of gelatin and plant-based capsules offering a broad range of innovative solutions for pharmaceutical and nutraceutical customers. Dosage Form Solutions: end-to-end development and manufacturing platform serving nutraceutical and pharmaceutical customers. Health Ingredients: provider of branded, science-backed nutrition ingredients serving joint health, energy and active lifestyle markets. Lone Star believes CHI is a high-quality, globally recognized platform with strong technical capabilities, different
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
